D 26344
Latest Information Update: 11 Dec 2002
At a glance
- Originator ASTA Medica [CEASED]
- Class Antineoplastics
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 11 Dec 2002 Discontinued - Preclinical for Cancer in Germany (unspecified route)
- 07 Feb 2000 Preclinical development for Cancer in Germany (Unknown route)